A multisite study of the overlap between symptoms and cognition in schizophrenia: Une étude multicentrique sur le chevauchement entre les symptômes et les troubles cognitifs chez les personnes atteintes de schizophrénie
ObjectiveCognitive impairment is a core feature of schizophrenia spectrum disorders. Our previous study on a first-episode psychosis cohort showed that symptoms related to impoverished/disorganized communication and motor impoverishment predicted verbal and working memory scores, respectively. This study aimed to explore those predictors in people across the range of illness chronicity.MethodsWe employed iterative Constrained Principal Component Analysis (iCPCA) to investigate the relationship between 15 cognitive measures from the MATRICS battery, including processing speed, attention, working, verbal and nonverbal memory, reasoning, and problem-solving, and 27 Positive and Negative Syndrome Scale (PANSS) items in 198 outpatients from two sites in Australia and one in Canada. The iCPCA method was used to determine symptoms that reliably predict specific combinations of cognitive measures while controlling Type I errors.ResultsWe found that a verbal memory and learning component was predicted by the PANSS item <i>Lack of Spontaneity and Flow of Conversation</i>, and a visual attention/working memory component was linked to the PANSS item <i>Motor Retardation</i>.ConclusionsThese accord with our previous findings in an early psychosis sample, that is, negative symptoms of diminished expression are key predictors of cognitive abilities in schizophrenia. Namely, communication and motor impoverishments predicted lower scores on tests of verbal memory, learning, visual attention, and working memory. These findings may inform personalized treatment approaches targeting cognitive deficits and negative symptoms in schizophrenia.
Authors
- R. Walter Heinrichs (ORCID: https://orcid.org/0000-0003-4884-4854)
- Joel O. Goldberg (ORCID: https://orcid.org/0000-0002-6409-6238)
- Sebastian Walther (ORCID: https://orcid.org/0000-0003-4026-3561)
- Martín Lepage (ORCID: https://orcid.org/0000-0003-4345-6502)
- Rafal M. Skiba (ORCID: https://orcid.org/0000-0002-5250-082X)
- David Jonathan Castle (ORCID: https://orcid.org/0000-0002-3075-1580)
- Todd Stephen Woodward (ORCID: https://orcid.org/0000-0001-8083-0079)
- Michael W. Best (ORCID: https://orcid.org/0000-0002-4632-5893)
- Abhijit Chinchani (ORCID: https://orcid.org/0000-0001-5950-4332)
- Ridha Joober (ORCID: https://orcid.org/0000-0003-3492-807X)
- Susan L. Rossell (ORCID: https://orcid.org/0000-0002-7415-8252)
- Katie M. Lavigne (ORCID: https://orcid.org/0000-0002-3918-691X)
- Mahesh Menon (ORCID: https://orcid.org/0000-0002-4007-0922)
- Amy M.N. Burns (ORCID: https://orcid.org/0000-0001-7132-8474)
- Ashok Malla
Institutions
- University of Bern (CH)
- University of Tasmania (AU)
- University of British Columbia (CA)
- University of Toronto (CA)
- York University (CA)
- St Vincent's Hospital Melbourne (AU)
- Matrix Institute on Addictions (US)
- BC Mental Health & Substance Use Services (CA)
- Universitätsklinikum Würzburg (DE)
- McGill University (CA)
- Swinburne University of Technology (AU)
Publication Details
- Journal
- The Canadian Journal of Psychiatry
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1177/07067437251387565
- Citations
- 1
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47